Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lomashvili, K. A.
Right arrow Articles by O’Neill, W. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lomashvili, K. A.
Right arrow Articles by O’Neill, W. C.
J Am Soc Nephrol 15:1392-1401, 2004
© 2004 American Society of Nephrology


BASIC SCIENCE

Phosphate-Induced Vascular Calcification: Role of Pyrophosphate and Osteopontin

Koba A. Lomashvili*, Scott Cobbs*, Randolph A. Hennigar{dagger}, Kenneth I. Hardcastle{ddagger} and W. Charles O’Neill*

*Renal Division, Department of Medicine, {dagger}Department of Pathology, and {ddagger}Department of Chemistry, Emory University, Atlanta, Georgia

Correspondence to W. Charles O’Neill, Emory University, Renal Division, WMB 338, 1639 Pierce Drive, Atlanta, Georgia. Phone: 404-727-3922; Fax: 404-727-3425; E-mail: woneill{at}emory.edu

ABSTRACT. Hyperphosphatemia is thought to underlie medial vascular calcification in advanced renal failure, but calcification can occur in other conditions in the absence of hyperphosphatemia, indicating that additional factors are important. To identify these factors, a model of medial calcification in rat aorta in vitro was developed. Aortic rings from rats were incubated in serum-free medium for 9 d, and calcification was measured as incorporation of 45Ca and confirmed by histology and x-ray diffraction. No calcification occurred in normal vessels despite elevated free Ca2+ and PO43– concentrations of 1.8 mM and 3.8 mM, respectively, but mechanical injury resulted in extensive calcification in the media. Co-incubation studies revealed that normal aortas produced a soluble inhibitor of calcification in injured vessels that was destroyed by alkaline phosphatase. Culture of normal aortas with alkaline phosphatase resulted in calcification of the elastic lamina identified as hydroxyapatite by x-ray diffraction. This effect of alkaline phosphatase was not due to dephosphorylation of osteopontin (OPN), and calcification was not increased in aortas from OPN-deficient mice. The inhibitor was identified as pyrophosphate on the basis of the calcification induced in aortas cultured with inorganic pyrophosphatase, the inhibition of calcification in injured aortas by pyrophosphate, and the production of inhibitory levels of pyrophosphate by normal aortas. No calcification occurred under any conditions at a normal PO43– concentration. It is concluded that elevated concentrations of Ca2+ and PO43– are not sufficient for medial vascular calcification because of inhibition by pyrophosphate. Alkaline phosphatase can promote calcification by hydrolyzing pyrophosphate, but OPN is not an endogenous inhibitor of calcification in rat aorta.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
A. Covic, P. Kothawala, M. Bernal, S. Robbins, A. Chalian, and D. Goldsmith
Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease
Nephrol. Dial. Transplant., November 11, 2008; (2008) gfn613v1.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. C. Shroff, R. McNair, N. Figg, J. N. Skepper, L. Schurgers, A. Gupta, M. Hiorns, A. E. Donald, J. Deanfield, L. Rees, et al.
Dialysis Accelerates Medial Vascular Calcification in Part by Triggering Smooth Muscle Cell Apoptosis
Circulation, October 21, 2008; 118(17): 1748 - 1757.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. L. Demer and Y. Tintut
Vascular Calcification: Pathobiology of a Multifaceted Disease
Circulation, June 3, 2008; 117(22): 2938 - 2948.
[Full Text] [PDF]


Home page
Circ. Res.Home page
K. A. Johnson, M. Polewski, and R. A. Terkeltaub
Transglutaminase 2 Is Central to Induction of the Arterial Calcification Program by Smooth Muscle Cells
Circ. Res., March 14, 2008; 102(5): 529 - 537.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. A. Johnson, W. Yao, N. E. Lane, P. Naquet, and R. A. Terkeltaub
Vanin-1 Pantetheinase Drives Increased Chondrogenic Potential of Mesenchymal Precursors in ank/ank Mice
Am. J. Pathol., February 1, 2008; 172(2): 440 - 453.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
I. Nikolov, N. Joki, T. Drueke, and Z. Massy
Beyond phosphate--role of uraemic toxins in cardiovascular calcification
Nephrol. Dial. Transplant., December 1, 2006; 21(12): 3354 - 3357.
[Full Text] [PDF]


Home page
Circ. Res.Home page
R. C. Johnson, J. A. Leopold, and J. Loscalzo
Vascular Calcification: Pathobiological Mechanisms and Clinical Implications
Circ. Res., November 10, 2006; 99(10): 1044 - 1059.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W. C. O'Neill
Pyrophosphate, Alkaline Phosphatase, and Vascular Calcification
Circ. Res., July 21, 2006; 99(2): e2 - e2.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
X. Qin, M. A. Corriere, L. M. Matrisian, and R. J. Guzman
Matrix Metalloproteinase Inhibition Attenuates Aortic Calcification
Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1510 - 1516.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Ketteler, G. Schlieper, and J. Floege
Calcification and Cardiovascular Health: New Insights Into an Old Phenomenon
Hypertension, June 1, 2006; 47(6): 1027 - 1034.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. M. Shanahan
Vascular calcification--a matter of damage limitation?
Nephrol. Dial. Transplant., May 1, 2006; 21(5): 1166 - 1169.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. A. Price, W. Si Chan, D. M. Jolson, and M. K. Williamson
The Elastic Lamellae of Devitalized Arteries Calcify When Incubated in Serum: Evidence for a Serum Calcification Factor
Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): 1079 - 1085.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. L. Reynolds, J. N. Skepper, R. McNair, T. Kasama, K. Gupta, P. L. Weissberg, W. Jahnen-Dechent, and C. M. Shanahan
Multifunctional Roles for Serum Protein Fetuin-A in Inhibition of Human Vascular Smooth Muscle Cell Calcification
J. Am. Soc. Nephrol., October 1, 2005; 16(10): 2920 - 2930.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. A. Lomashvili, W. Khawandi, and W. C. O'Neill
Reduced Plasma Pyrophosphate Levels in Hemodialysis Patients
J. Am. Soc. Nephrol., August 1, 2005; 16(8): 2495 - 2500.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. Henley, M. Colloton, R. C. Cattley, E. Shatzen, D. A. Towler, D. Lacey, and D. Martin
1,25-Dihydroxyvitamin D3 but not cinacalcet HCl (Sensipar(R)/Mimpara(R)) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism
Nephrol. Dial. Transplant., July 1, 2005; 20(7): 1370 - 1377.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Johnson, M. Polewski, D. van Etten, and R. Terkeltaub
Chondrogenesis Mediated by PPi Depletion Promotes Spontaneous Aortic Calcification in NPP1-/- Mice
Arterioscler. Thromb. Vasc. Biol., April 1, 2005; 25(4): 686 - 691.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP